155 related articles for article (PubMed ID: 11420700)
1. Defective caspase-3 relocalization in non-small cell lung carcinoma.
Joseph B; Ekedahl J; Lewensohn R; Marchetti P; Formstecher P; Zhivotovsky B
Oncogene; 2001 May; 20(23):2877-88. PubMed ID: 11420700
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial dysfunction is an essential step for killing of non-small cell lung carcinomas resistant to conventional treatment.
Joseph B; Marchetti P; Formstecher P; Kroemer G; Lewensohn R; Zhivotovsky B
Oncogene; 2002 Jan; 21(1):65-77. PubMed ID: 11791177
[TBL] [Abstract][Full Text] [Related]
3. Defective stress kinase and Bak activation in response to ionizing radiation but not cisplatin in a non-small cell lung carcinoma cell line.
Viktorsson K; Ekedahl J; Lindebro MC; Lewensohn R; Zhivotovsky B; Linder S; Shoshan MC
Exp Cell Res; 2003 Oct; 289(2):256-64. PubMed ID: 14499626
[TBL] [Abstract][Full Text] [Related]
4. Endogenously released Smac is insufficient to mediate cell death of human lung carcinoma in response to etoposide.
Bartling B; Lewensohn R; Zhivotovsky B
Exp Cell Res; 2004 Aug; 298(1):83-95. PubMed ID: 15242764
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy triggers apoptosis in a caspase-8-dependent and mitochondria-controlled manner in the non-small cell lung cancer cell line NCI-H460.
Ferreira CG; Span SW; Peters GJ; Kruyt FA; Giaccone G
Cancer Res; 2000 Dec; 60(24):7133-41. PubMed ID: 11156422
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C-epsilon promotes survival of lung cancer cells by suppressing apoptosis through dysregulation of the mitochondrial caspase pathway.
Ding L; Wang H; Lang W; Xiao L
J Biol Chem; 2002 Sep; 277(38):35305-13. PubMed ID: 12121973
[TBL] [Abstract][Full Text] [Related]
7. Defining characteristics of Types I and II apoptotic cells in response to TRAIL.
Ozören N; El-Deiry WS
Neoplasia; 2002; 4(6):551-7. PubMed ID: 12407450
[TBL] [Abstract][Full Text] [Related]
8. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460.
Huisman C; Ferreira CG; Bröker LE; Rodriguez JA; Smit EF; Postmus PE; Kruyt FA; Giaccone G
Clin Cancer Res; 2002 Feb; 8(2):596-606. PubMed ID: 11839682
[TBL] [Abstract][Full Text] [Related]
10. RasGTPase-activating protein is a target of caspases in spontaneous apoptosis of lung carcinoma cells and in response to etoposide.
Bartling B; Yang JY; Michod D; Widmann C; Lewensohn R; Zhivotovsky B
Carcinogenesis; 2004 Jun; 25(6):909-21. PubMed ID: 14742324
[TBL] [Abstract][Full Text] [Related]
11. Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions.
Eischen CM; Kottke TJ; Martins LM; Basi GS; Tung JS; Earnshaw WC; Leibson PJ; Kaufmann SH
Blood; 1997 Aug; 90(3):935-43. PubMed ID: 9242521
[TBL] [Abstract][Full Text] [Related]
12. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells.
Kandasamy K; Srivastava RK
Cancer Res; 2002 Sep; 62(17):4929-37. PubMed ID: 12208743
[TBL] [Abstract][Full Text] [Related]
13. Differences in expression of pro-caspases in small cell and non-small cell lung carcinoma.
Joseph B; Ekedahl J; Sirzen F; Lewensohn R; Zhivotovsky B
Biochem Biophys Res Commun; 1999 Aug; 262(2):381-7. PubMed ID: 10462484
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells.
Sun SY; Yue P; Hong WK; Lotan R
Cancer Res; 2000 Dec; 60(24):7149-55. PubMed ID: 11156424
[TBL] [Abstract][Full Text] [Related]
15. Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells.
Ekedahl J; Joseph B; Grigoriev MY; Müller M; Magnusson C; Lewensohn R; Zhivotovsky B
Exp Cell Res; 2002 Oct; 279(2):277-90. PubMed ID: 12243753
[TBL] [Abstract][Full Text] [Related]
16. Non-small and small cell lung carcinoma cell lines exhibit cell type-specific sensitivity to edelfosine-induced cell death and different cell line-specific responses to edelfosine treatment.
Shafer SH; Williams CL
Int J Oncol; 2003 Aug; 23(2):389-400. PubMed ID: 12851688
[TBL] [Abstract][Full Text] [Related]
17. Sensitization to CD95 ligand-induced apoptosis in human glioma cells by hyperthermia involves enhanced cytochrome c release.
Hermisson M; Wagenknecht B; Wolburg H; Glaser T; Dichgans J; Weller M
Oncogene; 2000 May; 19(19):2338-45. PubMed ID: 10822385
[TBL] [Abstract][Full Text] [Related]
18. Common regulation of apoptosis signaling induced by CD95 and the DNA-damaging stimuli etoposide and gamma-radiation downstream from caspase-8 activation.
Boesen-de Cock JG; Tepper AD; de Vries E; van Blitterswijk WJ; Borst J
J Biol Chem; 1999 May; 274(20):14255-61. PubMed ID: 10318846
[TBL] [Abstract][Full Text] [Related]
19. Apicidin, a histone deacetylase inhibitor, induces apoptosis and Fas/Fas ligand expression in human acute promyelocytic leukemia cells.
Kwon SH; Ahn SH; Kim YK; Bae GU; Yoon JW; Hong S; Lee HY; Lee YW; Lee HW; Han JW
J Biol Chem; 2002 Jan; 277(3):2073-80. PubMed ID: 11698395
[TBL] [Abstract][Full Text] [Related]
20. Futile caspase-8 activation during the apoptotic cell death induced by DNA damaging agents in human B-lymphoblasts.
Vit JP; Guillouf C; Rosselli F
Exp Cell Res; 2001 Sep; 269(1):2-12. PubMed ID: 11525634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]